RB Capital Management LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 3,400 shares of the company’s stock, valued at approximately $437,000.
Several other institutional investors and hedge funds have also recently modified their holdings of MKGAF. Frazier Financial Advisors LLC bought a new stake in shares of Merck KGaA during the 2nd quarter valued at about $25,000. Rakuten Securities Inc. bought a new stake in Merck KGaA during the second quarter valued at approximately $27,000. Solstein Capital LLC bought a new stake in Merck KGaA during the second quarter valued at approximately $33,000. Delos Wealth Advisors LLC purchased a new position in Merck KGaA in the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC purchased a new position in Merck KGaA in the 2nd quarter worth approximately $39,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $164.12 on Friday. The company’s fifty day moving average price is $163.35 and its 200-day moving average price is $149.06. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $21.21 billion, a price-to-earnings ratio of 25.06 and a beta of 0.96. Merck KGaA has a one year low of $116.68 and a one year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
